Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FOLD | BMY | AMGN | GILD | VRTX |
| Company | Amicus Therapeutics | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 9.97 | 43.56 | 309.53 | 65.18 | 419.00 |
| High | 10.00 | 44.81 | 314.60 | 65.22 | 421.18 |
| Low | 9.24 | 43.49 | 306.32 | 64.52 | 416.03 |
| Last | 9.48 | 44.74 | 312.86 | 64.58 | 418.99 |
| Change | -0.66 | +1.07 | +5.55 | -0.34 | +0.17 |
| % Change | -6.51% | +2.45% | +1.81% | -0.52% | +0.04% |
| Volume | 6,928,600 | 10,776,300 | 2,921,300 | 6,048,500 | 676,100 |
| 20-Day Average Volume | 2,902,295 | 14,356,360 | 2,907,275 | 7,462,300 | 1,114,570 |
| Previous Close | 10.14 | 43.67 | 307.31 | 64.92 | 418.82 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.39 | 46.17 | 279.47 | 66.10 | 400.63 |
| 20-Day Raw Stochastic | 13.11% | 22.60% | 84.27% | 5.83% | 80.77% |
| 20-Day Relative Strength | 31.62% | 35.71% | 68.03% | 31.74% | 60.08% |
| Weighted Alpha | -25.28 | -34.69 | +35.65 | -21.62 | +21.42 |
| Today's Opinion | 88% Sell | 100% Sell | 56% Buy | 100% Sell | 56% Buy |
| Previous Opinion | 88% Sell | 100% Sell | 56% Buy | 100% Sell | 56% Buy |
| Last Month's Opinion | 40% Sell | 48% Sell | 40% Sell | 100% Sell | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.11% since 05/02/24 | +2.38% since 05/02/24 | +12.38% since 05/02/24 | -1.15% since 05/02/24 | +4.71% since 05/02/24 |
| Low | 9.24 on 05/09/24 | 43.49 on 05/09/24 | 297.52 on 05/06/24 | 64.33 on 05/03/24 | 394.03 on 05/07/24 |
| High | 10.79 on 05/03/24 | 44.81 on 05/09/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 425.65 on 05/08/24 |
| 1-Month | |||||
| %Chg | -19.32% since 04/09/24 | -13.29% since 04/09/24 | +15.72% since 04/09/24 | -7.66% since 04/09/24 | +3.59% since 04/09/24 |
| Low | 9.24 on 05/09/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 11.46 on 04/10/24 | 51.28 on 04/10/24 | 322.60 on 05/03/24 | 69.76 on 04/10/24 | 425.65 on 05/08/24 |
| 3-Month | |||||
| %Chg | -30.04% since 02/09/24 | -10.18% since 02/09/24 | +7.47% since 02/09/24 | -12.34% since 02/09/24 | -0.93% since 02/09/24 |
| Low | 9.24 on 05/09/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 14.03 on 02/15/24 | 55.03 on 03/13/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | -4.96% since 11/09/23 | -11.25% since 11/09/23 | +18.48% since 11/09/23 | -13.87% since 11/09/23 | +13.68% since 11/09/23 |
| Low | 9.24 on 05/09/24 | 43.33 on 05/02/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 341.90 on 11/16/23 |
| High | 14.57 on 12/28/23 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,807,749 | 90,692,464 | 167,829,040 | 80,407,072 | 108,121,632 |
| Shares Outstanding, K | 296,176 | 2,027,100 | 536,435 | 1,245,077 | 258,053 |
| Annual Sales | 399,360,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -151,580,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 115,080,000 | 11,865,000,000 | 7,447,000,000 | 6,686,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -33,840,000 | -11,911,000,000 | -113,000,000 | -4,170,000,000 | 968,800,000 |
| 60-Month Beta | 0.80 | 0.45 | 0.60 | 0.22 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 05/09/24 | -4.40 on 04/25/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 |
| Latest Earnings Date | 05/09/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.59 | 16.50 | 16.11 | 27.81 |